Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer

95

Citations

28

References

2011

Year

Huqun, R. Ishikawa, Jialing Zhang, Hitoshi Miyazawa, Yoshiya Goto, Yoshihiko Shimizu, Koichi Hagiwara, Nobuyuki Koyama

Abstract

The current results indicated that EZH2 promotes progression and invasion of NSCLC, and its expression is a novel prognostic biomarker in NSCLC.

References

	Year	Citations

Page 1